Press release
Pharmaceutical Contract Research Services Market, 2021-2030 by Roots Analysis
London
Roots Analysis has announced the addition of “Pharmaceutical Contract Research Services Market, 2021-2030” report to its list of offerings.
Majority of the small companies as well as a few mid to large sized players, do not have the required capital or experience to undertake the development programs by themselves. Moreover, the costs associated with idle capacity for such specialized facilities are also high. As a result, the extent of outsourcing activities has considerably increased over the past few years.
To order this 290+ page report, which features 95+ figures and 130+ tables, please visit this link - https://www.rootsanalysis.com/reports/pharmaceutical-contract-research-services-market.html
Key Market Insights
Presently, more than 520 players claim to offer contract research services
Nearly 70% of the players provide contract research services for conducting clinical trials, followed by those offering services concerning regulatory affairs management (49%). It is worth mentioning that 41 service providers claim to have the required expertise to serve as one-stop-shops to cater to the needs of various pharmaceutical firms.
Partnership activity within this domain has grown significantly, since 2018
In the last three years, more than 190 agreements were inked by the pharmaceutical contract research service providers, with maximum activity being reported in 2020. Majority of the instances were related to acquisitions (20%), clinical trial agreements (18%), R&D agreements (14%), and research agreements (12%).
Close to 50 mergers and acquisitions were established in this domain, during the period 2018-2021
It was observed that majority of the deals were intracontinental (76%), involving participants from the same countries. Geographical consolidation and service portfolio expansion were observed to the major key value drivers of M&A activity in this domain. This was followed by instances of service portfolio addition and geographical expansion.
At present, companies offering clinical stage services represent majority of the market share (in terms of sales revenues)
By 2030, the pharmaceutical contract research market in North America is estimated to be worth USD 29 billion, representing an annualized growth rate of 9.7%. It is worth mentioning that the market in Asia-pacific is anticipated to grow at a relatively faster pace, during the forecast period.
.
To request a sample copy / brochure of this report, please visit this link - https://www.rootsanalysis.com/reports/pharmaceutical-contract-research-services-market.html
Key Questions Answered
Who are the leading players offering contract research services for small molecules?
Which partnership models are commonly adopted by stakeholders engaged in pharmaceutical contract research services market?
What are the key value drivers of the merger and acquisition activity observed within pharmaceutical contract research services market?
What are the likely future trends in contract research services market?
How is the current and future opportunity likely to be distributed across key market segments?
What is the total cost of ownership required to set up a pharmaceutical contract research organization?
The USD 59 billion (by 2030) financial opportunity within the pharmaceutical contract research service providers market has been analyzed across the following segments:
Scale of Operation
Discovery
Preclinical
Clinical
Target Therapeutic Area
Oncological Disorders
Infectious Diseases
Neurological Disorders
Inflammatory Disorders
Cardiovascular Disorders
Dermatological Disorders
Ophthalmic Diseases
Respiratory Disorders
Key Geographical Regions
North America
Europe
Asia- Pacific
Middle East
North Africa
Latin America
The report also features detailed profiles of key players (listed below); each profile features a brief overview of the company, its financial information (if available), information on the services offered and an informed future outlook.
Albany Molecular Research (AMRI)
BioDuro
BOC Sciences
Catalent Pharma
Charles River Laboratories
ChemDiv
Covance
Medpace
QPS
Concept Life Sciences
Evotec
ChemPartner
Pharmaron
Syngene
Torrent Pharma
WuXi AppTec
For additional details, please visit
https://www.rootsanalysis.com/reports/pharmaceutical-contract-research-services-market.html
or email sales@rootsanalysis.com
You may also be interested in the following titles:
1. Biospecimen Contract Research Services Market, 2021–2030
2. Biopharmaceutical CROs Market, 2021-2030
3. Cell and Gene Therapy CROs Market, 2021-2030
Contact:
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
ben.johnson@rootsanalysis.com
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Contract Research Services Market, 2021-2030 by Roots Analysis here
News-ID: 2433858 • Views: …
More Releases from Roots Analysis
Pharmaceutical Caps and Closures Market to Reach $12.49 Billion by 2035 | West P …
The global pharmaceutical caps and closures market, valued at USD 6.20 billion in 2024, is on track to reach USD 12.49 billion by 2035, advancing at a CAGR of 6.6% over the forecast period. This growth reflects a fundamental shift in how drug manufacturers approach primary packaging: as biologics, injectables, and personalized therapies multiply, the integrity of the container-closure system has become as critical as the drug formulation itself. For…
Biopesticides Market to Reach $20.46 Billion by 2035, Growing at 9.6% CAGR | Bay …
The global biopesticides market, valued at USD 8.22 billion in 2025, will reach USD 9.00 billion in 2026 and climb to USD 20.46 billion by 2035, advancing at a CAGR of 9.6% over the forecast period. Surging demand for organic food, tightening regulatory restrictions on synthetic agrochemicals, and a decisive shift toward sustainable farming are together compressing timelines for adoption across both developed and emerging agricultural economies.
To explore the complete…
Amyotrophic Lateral Sclerosis Treatment Market to Reach $1.38 Billion by 2035, G …
The global amyotrophic lateral sclerosis treatment market, valued at USD 0.79 billion in 2024, will grow to USD 1.38 billion by 2035, advancing at a compound annual growth rate of 5.2% over the forecast period. Rising disease incidence, a deepening clinical pipeline, and a wave of regulatory approvals are pushing this long-underserved market toward sustained commercial expansion. For pharmaceutical companies, investors, and healthcare strategists, the next decade presents a concrete…
Global Skincare Market to Reach $407 Billion by 2035 at 7.4% CAGR | L'Oreal, Est …
The global skincare market, valued at USD 184.6 billion in 2024, will grow to USD 198.5 billion in 2025 and reach USD 407 billion by 2035, advancing at a compound annual growth rate of 7.4% over the forecast period. The scale of this expansion reflects a fundamental shift in how consumers worldwide approach personal care, skin health, and daily wellness routines, making this one of the most commercially significant categories…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
